CLINICAL_TRIALS
research
· 2026-02-17
Clinical Trial Update: Relative Contribution of Brain Insulin Action for Postprandial Metabolism [NA]
Summary
This is an update on an active University of Ulm clinical trial evaluating the relative contribution of brain insulin action to postprandial glucose metabolism.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Ulm | Conditions: Glucose Metabolism Disorders | NA | Status: ACTIVE_NOT_RECRUITING